Literature DB >> 1676831

Regulation of CCK release in cerebral cortex by N-methyl-D-aspartate receptors: sensitivity to APV, MK-801, kynurenate, magnesium and zinc ions.

R Bandopadhyay1, J de Belleroche.   

Abstract

Cholecystokinin octapeptide (CCK) is an abundant neuropeptide of cerebral cortex but its function in this region is largely unknown. In this study we have examined the effect of glutamate receptor activation on the depolarisation-induced release of CCK-like immunoreactivity from tissue slices of rat cerebral cortex. The K(+)-evoked release of cholecystokinin was found to be significantly increased by the three excitatory amino acid agonists effective against glutamate receptor subtypes. N-methyl-D-aspartate (NMDA), kainic acid and quisqualate. The facilitation of CCK release by NMDA was examined in more detail and shown to be significantly attenuated by Mg2+ (2.5 mM), Zn2+ (50 microM), MK-801 (0.1 and 0.3 microM), aminophosphonovaleric acid (100 microM) and kynurenic acid (100 microM and 300 microM). These results support the conclusion that release of CCK in cerebral cortex is modulated by the NMDA receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676831     DOI: 10.1016/0143-4179(91)90108-u

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  4 in total

1.  CCKB receptor activation reduces glutamate-induced depolarization in slices of rat cerebral cortex.

Authors:  J Harro; P Westerling; L Oreland
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 2.  Interaction between Zinc, GPR39, BDNF and Neuropeptides in Depression.

Authors:  Katarzyna Mlyniec
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

3.  Intervention effects of ganoderma lucidum spores on epileptiform discharge hippocampal neurons and expression of neurotrophin-4 and N-cadherin.

Authors:  Shu-Qiu Wang; Xiao-Jie Li; Shaobo Zhou; Di-Xiang Sun; Hui Wang; Peng-Fei Cheng; Xiao-Ru Ma; Lei Liu; Jun-Xing Liu; Fang-Fang Wang; Yan-Feng Liang; Jia-Mei Wu
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

Review 4.  Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A "Dimmer-Switch" Hypothesis.

Authors:  Santiago J Ballaz; Michel Bourin
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.